Dr. Nicholas Arpaia
Columbia University
Connecting CIP-Net researchers, patients, patient advocates, and the broader public through accessible communication, meaningful dialogue, and community-informed cancer immunoprevention research.
To enhance awareness and impact of cancer immunoprevention research through multi-directional engagement among researchers, patients, patient advocates, and the broader public.
Columbia University
University of Southern California
The Working Group supports CIP-Net by helping translate scientific advances into accessible resources and by integrating patient and community perspectives into network activities.
Featuring conversations among researchers, patient advocates, and community voices on cancer immunoprevention, cancer interception, and patient-centered prevention research.
Developing lay summaries, infographics, visual explainers, and patient-friendly research highlights to make network science accessible to broader audiences.
Sharing accessible research updates through CIP-Net communication platforms and amplifying network activities across institutions and communities.
Developing a patient advocate-focused panel exploring risk perception, prevention, vaccine acceptance, toxicity tolerance, and patient-informed research priorities.
Exploring opportunities with professional societies, working groups, and advocacy organizations to expand outreach and trainee visibility.
Building connections with patient advocacy groups and foundations to support broader awareness and meaningful two-way engagement.
Members include CIP-Net investigators, DRCC representatives, NCI program officers, CIP-Net trainees, and patient advocates.
For questions about the Community Engagement Working Group or to suggest outreach opportunities, please contact the CIP-Net Data and Resource Coordinating Center.